RECRUITING

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

SURVIVORS Study participants are being asked to take part in this research study called HODNIRS because the participant is a survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. The study is being done to help investigators understand the link between long term effects of chest radiation and bleomycin for HL and brain function in survivors. Primary Objective To evaluate dynamic changes in CBF and oxygenation during exercise with Near Infrared Spectroscopy (NIRS) in HL survivors and non-cancer controls matched for age, sex, race, and ethnicity. . Secondary Objectives To examine the degree of CO2 clearance (DLCO/ETCO2) during rest and exercise in Hodgkin Lymphoma (HL) survivors compared to non-cancer controls matched for age, sex, race, and ethnicity. CONTROLS Volunteers are being asked to take part in this research study because they are non-first degree relative or friend of someone who received treatment for a childhood cancer or similar illness at St. Jude Children's Research Hospital or are an employee/affiliate of St. Jude Children's Research Hospital and have agreed to be a St. Jude Life Cohort Study (SJLIFE) community control.

Official Title

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

Quick Facts

Study Start:2024-05-06
Study Completion:2027-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06421987

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Completed bleomycin and/or thoracic radiation therapy for HL at SJCRH.
  2. * \<21-years old at diagnosis; currently ≥18-years of age and ≥2-years post therapy.
  3. * SJLIFE or ACT/SJLIFE participants
  4. * English language proficiency.
  5. * SJLIFE control.
  6. * ≥18-years of age at the time of enrollment with age sampling to broadly match the HL survivors.
  1. * History of cranial or total-body irradiation therapy.
  2. * History of intrathecal or high dose intravenous antimetabolite therapy.
  3. * History of head injury or diagnosis of a genetic disorder associated with cognitive impairment.

Contacts and Locations

Study Contact

Nicholas Phillips, PhD
CONTACT
866-278-5833
referralinfo@stjude.org

Principal Investigator

Nicholas Phillips, PhD
PRINCIPAL_INVESTIGATOR
St. Jude

Study Locations (Sites)

St. Jude Children's Research Hospital
Memphis, Tennessee, 38105
United States

Collaborators and Investigators

Sponsor: St. Jude Children's Research Hospital

  • Nicholas Phillips, PhD, PRINCIPAL_INVESTIGATOR, St. Jude

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-06
Study Completion Date2027-03

Study Record Updates

Study Start Date2024-05-06
Study Completion Date2027-03

Terms related to this study

Additional Relevant MeSH Terms

  • Hodgkin Lymphoma, Adult